Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND NF1, NFNS, 4763, ENSG00000196712, P21359
109 results:

  • 1. Efficacy, safety and genomic analysis of SCT200, an anti-EGFR monoclonal antibody, in patients with fluorouracil, irinotecan and oxaliplatin refractory RAS and BRAF wild-type metastatic colorectal cancer: a phase Ⅱ study.
    Yang L; Zhang W; Fan N; Cao P; Cheng Y; Zhu L; Luo S; Zong H; Bai Y; Zhou J; Deng Y; Ba Y; Liu T; Aili M; Yin X; Gu K; Dai G; Ying J; Shi J; Gao Y; Li W; Yu G; Xie L; Gai W; Wang Y; Meng P; Shi Y
    EBioMedicine; 2024 Feb; 100():104966. PubMed ID: 38217945
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Whole-exome sequencing reveals mutational profiles of anorectal and gynecological melanoma.
    Sun W; Liu K; Zhou H; Zhao F; Dong Y; Xu Y; Kong Y; Wang M; Cheng X; Chen Y
    Med Oncol; 2023 Oct; 40(11):330. PubMed ID: 37831226
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Neurofibromatosis type 1 mosaicism in patients with constitutional mismatch repair deficiency.
    Guerrini-Rousseau L; Pasmant E; Muleris M; Abbou S; Adam-De-Beaumais T; Brugieres L; Cabaret O; Colas C; Cotteret S; Decq P; Dufour C; Guillerm E; Rouleau E; Varlet P; Zili S; Vidaud D; Grill J
    J Med Genet; 2024 Jan; 61(2):158-162. PubMed ID: 37775264
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Molecular typing and mutational characterization of rectal neuroendocrine neoplasms.
    Duan X; Zhao M; Yin X; Mi L; Shi J; Li N; Han X; Han G; Wang J; Hou J; Yin F
    Cancer Med; 2023 Aug; 12(15):16207-16220. PubMed ID: 37387515
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. PDE4DIP contributes to colorectal cancer growth and chemoresistance through modulation of the nf1/RAS signaling axis.
    Pan R; Dai J; Liang W; Wang H; Ye L; Ye S; Lin Z; Huang S; Xiong Y; Zhang L; Lu L; Wang O; Shen X; Liao W; Lu X
    Cell Death Dis; 2023 Jun; 14(6):373. PubMed ID: 37355626
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. An MRI Deep Learning Model Predicts Outcome in Rectal cancer.
    Jiang X; Zhao H; Saldanha OL; Nebelung S; Kuhl C; Amygdalos I; Lang SA; Wu X; Meng X; Truhn D; Kather JN; Ke J
    Radiology; 2023 Jun; 307(5):e222223. PubMed ID: 37278629
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Genomic landscape of locally advanced rectal adenocarcinoma: Comparison between before and after neoadjuvant chemoradiation and effects of genetic biomarkers on clinical outcomes and tumor response.
    Lee TH; Jang BS; Chang JH; Kim E; Park JH; Chie EK
    Cancer Med; 2023 Jul; 12(14):15664-15675. PubMed ID: 37260182
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Constitutional Mismatch Repair Deficiency Syndromes, a Neurofibromatosis 1 Mimicker That Hinders Timely Management.
    Mir A; AlMudhry M; AlOtaibi W; AlHazmi R; AlBaradie R; AlHarbi Q; Bashir S; Chamdine O; Housawi Y
    J Pediatr Hematol Oncol; 2023 Jul; 45(5):e613-e620. PubMed ID: 36897649
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Canonical and uncanonical pathogenic germline variants in colorectal cancer patients by next-generation sequencing in a European referral center.
    Poliani L; Greco L; Barile M; Dal Buono A; Bianchi P; Basso G; Giatti V; Genuardi M; Malesci A; Laghi L;
    ESMO Open; 2022 Dec; 7(6):100607. PubMed ID: 36356413
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. A Rare Case of Multiple Gastrointestinal Stromal Tumors Coexisting with a Rectal Adenocarcinoma in a Patient with Attenuated Familial Adenomatous Polyposis Syndrome and a Mini Review of the Literature.
    Paramythiotis D; Kyriakidis F; Karlafti E; Koletsa T; Tsakona A; Papalexis P; Ioannidis A; Malliou P; Netta S; Michalopoulos A
    Medicina (Kaunas); 2022 Aug; 58(8):. PubMed ID: 36013583
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Genomic Landscape of Advanced Solid Tumors in Circulating Tumor DNA and Correlation With Tissue Sequencing: A Single Institution's Experience.
    Gerratana L; Movarek M; Wehbe F; Katam N; Mahalingam D; Donahue J; Shah A; Chae YK; Mulcahy M; Tsarwhas D; Villaflor V; Kalyan A; Hussein M; Patel J; Chandra S; Platanias LC; Gradishar W; Cristofanilli M; Behdad A
    JCO Precis Oncol; 2022 Jun; 6():e2100289. PubMed ID: 35772051
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Neurofibromatosis type 1: A comparison of the 1997 NIH and the 2021 revised diagnostic criteria in 75 children and adolescents.
    Angelova-Toshkina D; Holzapfel J; Huber S; Schimmel M; Wieczorek D; Gnekow AK; Frühwald MC; Kuhlen M
    Genet Med; 2022 Sep; 24(9):1978-1985. PubMed ID: 35713653
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Inflammatory leiomyosarcoma/rhabdomyoblastic tumor: A report of two cases with novel genetic findings.
    Sukhanova M; Obeidin F; Streich L; Alexiev BA
    Genes Chromosomes Cancer; 2022 Nov; 61(11):653-661. PubMed ID: 35655404
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Negative Ultraselection of Patients With
    Randon G; Maddalena G; Germani MM; Pircher CC; Manca P; Bergamo F; Giordano M; Sposetti C; Montagna A; Vetere G; Zambelli L; Rasola C; Boccaccino A; Pagani F; Ambrosini M; Massafra M; Fontanini G; Milione M; Fassan M; Cremolini C; Lonardi S; Pietrantonio F
    JCO Precis Oncol; 2022 Apr; 6():e2200037. PubMed ID: 35544729
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Anticancer drug resistance: An update and perspective.
    Nussinov R; Tsai CJ; Jang H
    Drug Resist Updat; 2021 Dec; 59():100796. PubMed ID: 34953682
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Challenges in the diagnosis of neurofibromatosis type 1 (nf1) in young children facilitated by means of revised diagnostic criteria including genetic testing for pathogenic nf1 gene variants.
    Kehrer-Sawatzki H; Cooper DN
    Hum Genet; 2022 Feb; 141(2):177-191. PubMed ID: 34928431
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Identification of RAS mutant biomarkers for EGFR inhibitor sensitivity using a systems biochemical approach.
    McFall T; Stites EC
    Cell Rep; 2021 Dec; 37(11):110096. PubMed ID: 34910921
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Expression of neurofibromin 1 in colorectal cancer and cetuximab resistance.
    Tak E; Kim M; Cho Y; Choi S; Kim J; Han B; Kim HD; Jang CS; Kim JE; Hong YS; Kim SY; Kim TW
    Oncol Rep; 2022 Jan; 47(1):. PubMed ID: 34779495
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Molecular characteristics and clinical outcomes of patients with Neurofibromin 1-altered metastatic colorectal cancer.
    Arai H; Elliott A; Millstein J; Xiu J; Ou FS; Innocenti F; Wang J; Battaglin F; Jayachandran P; Kawanishi N; Soni S; Zhang W; Sohal D; Goldberg RM; Hall MJ; Scott AJ; Khushman M; Hwang JJ; Lou E; Weinberg BA; Lockhart AC; Shields AF; Abraham JP; Magee D; Stafford P; Zhang J; Venook AP; Korn WM; Lenz HJ
    Oncogene; 2022 Jan; 41(2):260-267. PubMed ID: 34728807
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Identification of Prognostic Genes for Colon cancer through Gene Co-expression Network Analysis.
    Wang DW; Yang ZS; Xu J; Yang LJ; Yang TC; Wang HQ; Feng MH; Su F
    Curr Med Sci; 2021 Oct; 41(5):1012-1022. PubMed ID: 34542829
    [TBL] [Abstract] [Full Text] [Related]  


    of 6.